Tarsus PharmaceuticalsTARS
那斯達克 · USD
71.49
-1.95
(-2.66%)
收盤 08/21 03:59 (UTC+8)
08/21 03:59 (UTC+8)
Tarsus PharmaceuticalsTARS
71.49
-1.95
(-2.66%)
財務數據
損益表
- 0.28
- 0.41
- 0.48
- 0.66
- 0.78
- 1.03
- 1.19
- 1.52
- 1.62
- 1.74
- 111.18
- 47.80
- 17.90
- 38.01
- 17.96
- 31.05
- 15.62
- 27.78
- 6.85
- 7.32
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 173,912 | 162,054 | 151,668 | 118,697 | 102,660 | 78,335 | 66,408 | 48,118 | 40,813 | 27,614 |
營業成本 | 12,113 | 9,396 | 10,927 | 8,309 | 6,237 | 5,211 | 4,926 | 3,242 | 3,004 | 1,654 |
營業毛利 | 161,799 | 152,658 | 140,741 | 110,388 | 96,423 | 73,124 | 61,482 | 44,876 | 37,809 | 25,960 |
營業費用 | 181,707 | 158,780 | 148,717 | 124,917 | 118,607 | - | 85,903 | - | 71,111 | 63,644 |
研發費用 | 31,010 | 22,351 | 18,035 | 16,284 | 15,594 | 14,409 | 16,873 | 12,128 | 12,319 | 12,066 |
推銷及管理費用 | 150,697 | 136,429 | 130,682 | 108,633 | 103,013 | 84,995 | 69,030 | 57,910 | 58,792 | 51,578 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -19,908 | -6,122 | -7,976 | -14,529 | -22,184 | -26,280 | -24,421 | -25,162 | -33,302 | -37,684 |
其他收入及費用 | 6,229 | 3,635 | 3,876 | 4,212 | 4,084 | 3,373 | 4,211 | 4,187 | 2,712 | 3,521 |
利息費用 | 2,156 | 2,128 | 2,214 | 2,268 | 2,240 | 2,213 | 2,312 | 2,445 | 2,109 | 983 |
稅前純益 | -15,835 | -4,615 | -6,314 | -12,585 | -20,340 | -25,120 | -23,113 | -23,420 | -33,290 | -35,731 |
所得稅 | 2,716 | 2,352 | 2,059 | - | - | - | - | - | - | - |
稅後純益 | -18,551 | -6,967 | -8,373 | -12,585 | -20,340 | -25,120 | -23,113 | -23,420 | -33,290 | -35,731 |
基本每股稅後盈餘(元) | -0.43 | -0.16 | -0.20 | -0.30 | -0.48 | -0.64 | -0.60 | -0.61 | -0.88 | -1.01 |
稀釋每股稅後盈餘(元) | -0.43 | -0.16 | -0.19 | -0.29 | -0.47 | -0.64 | -0.59 | -0.59 | -0.88 | -1.01 |
基本平均股數(千股) | 43393.00 | 42956.00 | 42784.00 | 42607.00 | 42360.00 | 39345.00 | 38560.00 | 38381.00 | 37823.00 | 35300.00 |
稀釋平均股數(千股) | 43393.00 | 42956.00 | 42784.00 | 42607.00 | 42360.00 | 39345.00 | 38560.00 | 38381.00 | 37823.00 | 35300.00 |
還原基本每股稅後盈餘(元) | -0.43 | -0.16 | -0.20 | -0.30 | -0.48 | -0.64 | -0.60 | -0.61 | -0.88 | -1.01 |
還原稀釋每股稅後盈餘(元) | -0.43 | -0.16 | -0.19 | -0.29 | -0.47 | -0.64 | -0.59 | -0.59 | -0.88 | -1.01 |
還原基本平均股數(千股) | 43,393 | 42,956 | 42,784 | 42,607 | 42,360 | 39,345 | 38,560 | 38,381 | 37,823 | 35,300 |
還原稀釋平均股數(千股) | 43,393 | 42,956 | 42,784 | 42,607 | 42,360 | 39,345 | 38,560 | 38,381 | 37,823 | 35,300 |
EBITDA(千元) | -13,275 | -2,740 | -4,426 | -11,239 | -19,210 | -23,622 | -21,712 | -21,706 | -32,139 | -34,654 |